Integration of RWE in HTA - Quality HTA is pleased to announce the article "Integration of Real-world Evidence from Different Data Sources in Health Technology Assessment", written by Pooyeh Grail, Jason R. Guertin, Kelvin K.W. Chan, and Mina Tadrous, published by the Frontier Journal of Pharmacy & Pharmaceutical Sciences is available now. This study aimed [...]
Digital Health & Health Technology Assessment - Quality HTA is honoured to present "Digital Health and Health Technology Assessment" by Pooyeh Graili, the Founder and Principal at Quality HTA. This one-hour talk will be held at IEEE , "the world's largest technical professional organization dedicated to advancing technology for the benefit of humanity", Toronto section [...]
Conditional Funding Recommendations - Quality HTA is pleased to announce its recent paper "Conditional Funding Recommendations for Drugs in Canada: A Cross-Sectional Analysis" written by Pooyeh Grail and published online by Applied Health Economics and Health Policy is available now. This study aimed to review the conditional reimbursement recommendations issued by CADTH and explore the [...]
Quality HTA at the EU ISPOR 2022 - Quality HTA is pleased to announce the presentation of “Conditional Recommendations by the Canadian Agency for Drugs and Technologies in Health (CADTH)” at the ISPOR Conference 2022. This poster will be presented virtually by Pooyeh Graili on Monday, November 7, from 10:30 to 13:15 CET / 4:30 - [...]
CAPT-ACTP Conference 2022 - Quality HTA is pleased to announce the presentation of "Change and Trends in Conditional Recommendations; Analysis of CADTH Reports" at CAPT Conference 2022. This poster will be presented on Monday afternoon, October 17 at MaRS Discovery District, Toronto. The conference information is available here!
The CADTH Post-Market Drug Program - CADTH has launched its Post-Market Evaluation Program to address the uncertainties around the appropriate use of drugs, their long-term safety, and effectiveness after use in the real world. The cornerstone of this program, CoLab, is an evidence-generation network to support senior-level decision-makers. This network is comprised of experts in [...]
Artificial Intelligence (AI) in Health Technology Assessment (HTA) - An hour presentation, AI in HTA, including the Q&A session, presented by Pooyeh Graili at ValleyML virtual meeting on October 12, 2021, is now publicly available on Vimeo. This presentation aimed to provide some insights into what HTA is and its components, who its audiences are, [...]
Quality HTA in ValleyML 2021 - Quality HTA is honoured to present AI in HTA. Pooyeh Graili, the principal consultant at Quality HTA, will talk about "Artificial Intelligence in Health Technology Assessment" on October 12, 2021, at 13:00 EDT. The VallyMl virtual event will be held from October 12 - 14 on various topics, including AI in healthcare. To register: here [...]
Quality HTA & HTAi Webinar - Quality HTA is honoured to contribute to holding a webinar "Artificial Intelligence in Outcomes Research" presenting by Pooyeh Graili, the principal consultant at Quality HTA, in the third Quarterly Meeting of RWE & AI IG (Real-world Evidence & Artificial Intelligence Interest Group) at HTAi on Thursday, September 16 at [...]
Over 100 Viewers in Four Months - Quality HTA is honored with its last article, "Artificial intelligence in outcomes research: a systematic scoping review" published four months ago by Expert Rev Pharmacoecon Outcomes Res Journal @tandfonline, which has been viewed over 100 times! Thanks very much to the viewers for their interest, the co-authors for [...]